Cite
HARVARD Citation
Kraaij, T. et al. (n.d.). OP0302 Significant reductions of pathogenic autoantibodies by synergetic rituximab and belimumab treatment effectively inhibits neutrophil extracellular traps in severe, refractory sle - the synbiose study. Annals of the rheumatic diseases. p. 181. [Online].